Navigation Links
Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
Date:6/29/2009

ral and satellite pharmacies and direct patient care areas, due to its self-contained form, ISO Class 5 environment, and small "foot print". Pharmacies may, for the first time, choose a robotic configuration that suits their needs, rather than being forced into the dated alternative of "one-size-fits-all, million-dollar-plus" robots designed 10 years ago. Whether a Pharmacy chooses a single or multiple i.v.STATION configurations, it will benefit from fully automated compounding while producing its ready-to-administer IV doses in a variety of syringe, bag, vial, and tamper-evident caps from diverse medical suppliers.

"Grifols is everything we look for in a strategic partner for Health Robotics: company stability, world-class service infrastructure, well-developed marketing channels, and experience in IV therapy, clinical nutrition, and pharmacy automation. I was extremely impressed to see their manufacturing and biomedical expertise and the large footprint they have achieved with over 100 hospitals utilizing Pyxis MedStation technologies in their core markets. I hope this is just the beginning of a long-term partnership expanding into manufacturing and other unexplored fields in Robotics pharmacy automation such as total parenteral nutrition," stated Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intravenous medication preparation, compounding, and dispensing Robots, with fifty times more units sold that all of its competitors combined, and providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare (hazardous IVs), i.v.STATION (non-hazardous IVs), and the current development of TPNstation (parenteral nutrition) have and will greatly contribute to ease global hospitals' and clinics' growing pressures to improve patient safety through the
'/>"/>

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ndomized, controlled study comparing standard cons... called percutaneous disc decompression for painfu...ts help patients in the short run, only disc decom...ater. Results of the study, the first of its kind,... Radiological Society of North America (RSNA). , ...
(Date:12/1/2009)... Advocate Christ Medical Center in Oak L...ey transplant center and the first for Chicago&rsq... approval of the hospital’s plans today (Dec...vices Review Board. , Spr... Center in Oak Lawn, Ill. has become the state&rs...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.c...available in its catalogue: ,, Emerging Clini...he changing healthcare and regulatory environment ...ging-Clinical-Trial-Locations---India-Market-dynam...ironment.html ,, Over the last decade pharmace...
(Date:12/1/2009)...INGTON, Dec. 1 The Kerl...ic in Los Angeles, has agreed to pay the United St...ived illegal kickbacks from HealthSouth Corporatio..., The settlement resolves allegations that Healt...f stock option grants, donations to the Kerlan Job...
(Date:12/1/2009)... ANGELES, Dec. 1 A decision issued...r Relations Board (NLRB) has put at risk the guara... Kaiser Permanente RNs, social workers, and profes...ked for years to achieve standards at Kaiser that ...ssional care our patients need," said Jeanette Cry...
Breaking Medicine News(10 mins):Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2
...s for Rapid Onsite Pathogen Detection , , ST. GEO...response to the recent outbreak of swine flu and r... test for its GeneSTAT(R) pathogen detection platf...ounds. The Company anticipates having a product r...
...ation,s leader in pain prescription monitoring, an...ment with Aetna to offer Aetna,s network of provid... medication monitoring process. , , Ameritox,s p...patients are taking their pain medication consiste...
...ns believe there is some risk for a catastrophic p...ational study among 2,225 members of the general p...hat there is some risk that the current situation ... study was conducted by HCD Research and the Muhl...
...n,s largest organization of registered nurses toda...ontainment and prevention of a broader swine flu p...tion,s call on Congress Tuesday to allocate $1.5 b...healthcare infrastructure badly eroded after years...
...ction with HBO, Cox Communications will allow all ...scribe to HBO -- to have free access to its upcomi...eginning May 11, digital cable customers can acces... , , "Cox is happy to partner with HBO to presen...
...d Officials to Pass Community Choice Act , , WASH...DAPT disability rights organization, and home care...the halls of Congress today to deliver an urgent m...mericans. , , The rally was part of a larger effo...
Other Medicine News:Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 2Health News:DxNA to Use its Rapid Detection Platform to Simplify Testing for Swine Flu (H1N1 Virus) 3Health News:Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services 2Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 2Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 3Health News:General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic 4Health News:Nurses Call for Broader Action to Combat Swine Flu: Boost Public Health, Moratorium on Closures, Layoffs, Suspend Insurance Charges that Discourage Prevention 2Health News:Nurses Call for Broader Action to Combat Swine Flu: Boost Public Health, Moratorium on Closures, Layoffs, Suspend Insurance Charges that Discourage Prevention 3Health News:Cox Offers Free Access to HBO(R) Documentary Series, The Alzheimer's Project, to All Digital Customers 2Health News:ADAPT Disability Rights Activists and SEIU Home Care Attendants Tell Congress: Community Choice is a Right 2
(Date:12/2/2009).... 2 Novartis announced today that ...n Tasigna® (nilotinib) 200 mg capsules in a f...trength of the company,s hematology portfolio in a..., at the 51st American Society of Hematology (ASH)...any,s current therapies and investigational agents...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Medical Oxygen Systems - Global Market Opp...164334/Medical-Oxygen-Systems---Global-Market-Oppo...tems market for home healthcare setting is reckone...th expectations stem from demographic factors such...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Molecular Diagnostics - A World Market Revi...lecular-Diagnostics---A-World-Market-Review.html ... by several growth factors that include the need f...combine optimized sample preparation, analysis, an...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 1LifeNet Health Announces First Bio Implant with New Preservation Technology 6088 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 1RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas Fort Worth Area 6084 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 1Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 2Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 3Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 4Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 5Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 6Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Now Available in Pharmacies Nationwide 6079 7
... EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 6, 200...nnounced today that two,abstracts exploring Phase ...fe in treatment-failure gout patients will be,pres...ULAR) 2007,Annual Congress taking place June 13 - ...recombinant porcine urate oxidase currently,in Pha...
... SAN DIEGO--(BUSINESS WIRE)--Jun 7, 2007 - Inovio ...development of DNA vaccines,for cancers and infect...o treat localized cancers, announced today that th... positive interim,safety and tolerability data on ... using Inovio,s electroporation technology for,int...
Other Medicine Technology:Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 2Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 3Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5
Tying Forceps - Curved
Nordan Straight Tying Forceps
McPherson Angled Tying Forceps
Clayman - McPherson Angled Tying Forceps
Medicine Products: